Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01447810 : Constraint-Induced Movement Therapy in a Pediatric Oncology Population
PhaseN/A
AgesMin: 2 Years Max: 7 Years
Eligibility
Inclusion Criteria:

- Diagnosed hemiplegia of an upper extremity as documented by physician or
rehabilitation clinician in the medical record

- Diagnosis of brain tumor

- English speaking

- Participant has demonstrated the ability in the past to move the elbow >70 degrees
and has some purposeful movement in the hand (ability to initiate a gross grasp).

- Parent/legal guardian is willing to give consent to participate in the study.

- Child is willing to give assent in the study if seven years old.

Exclusion Criteria:

- Severe hemiplegia and resulting active range of motion deficits at the affected upper
extremity as defined by the following:

- < 30 degrees active shoulder flexion or abduction

- Inability to initiate active elbow flexion or extension.

- Inability to initiate movements at the of wrist, finger or thumb

- Uncontrolled seizures that interfere with daily activities, as this would interfere
with the participant's ability to fully participate in the CI Therapy program.

- Pain that significantly interferes with the participant's ability to fully
participate in the intensive therapy program. This includes pain related to
subluxation of the shoulder, as measured by a pain rating of 5/10 or greater on the
FACES or Numeric Pain Scale.

- Currently receiving oral or intravenous chemotherapy or radiation therapy.

- Inability or unwillingness of legal guardian to give written informed consent.

- Child is unwilling to give assent if seven years old
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01447810      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740